Literature DB >> 27345218

Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial.

Jane Robertson1, Phillip McNamee2, Gerry Molloy3, Gill Hubbard4, Alan McNeill5, Prasad Bollina5, Daniel Kelly6, Liz Forbat7.   

Abstract

INTRODUCTION: Surgery for prostate cancer can result in distressing side effects such as sexual difficulties, which are associated with lower levels of dyadic functioning. The study developed and tested an intervention to address sexual, relational, and emotional aspects of the relationship after prostate cancer by incorporating elements of family systems theory and sex therapy. AIMS: To develop and test the feasibility and acceptability of relational psychosexual treatment for couples with prostate cancer, determine whether a relational-psychosexual intervention is feasible and acceptable for couples affected by prostate cancer, and determine the parameters for a full-scale trial.
METHODS: Forty-three couples were recruited for this pilot randomized controlled trial and received a six-session manual-based psychosexual intervention or usual care. Outcomes were measured before, after, and 6 months after the intervention. Acceptability and feasibility were established from recruitment and retention rates and adherence to the manual. MAIN OUTCOME MEASURES: The primary outcome measurement was the sexual bother subdomain of the Expanded Prostate Cancer Index Composite. The Hospital Anxiety and Depression Scale and the 15-item Systemic Clinical Outcome and Routine Evaluation (SCORE-15) were used to measure emotional and relational functioning, respectively.
RESULTS: The intervention was feasible and acceptable. The trial achieved adequate recruitment (38%) and retention (74%) rates. The intervention had a clinically and statistically significant effect on sexual bother immediately after the intervention. Small decreases in anxiety and depression were observed for the intervention couples, although these were not statistically significant. Practitioners reported high levels of adherence to the manual.
CONCLUSION: The clinically significant impact on sexual bother and positive feedback on the study's feasibility and acceptability indicate that the intervention should be tested in a multicenter trial. The SCORE-15 lacked specificity for this intervention, and future trials would benefit from a couple-focused measurement.
Copyright © 2016 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Couple Therapy; Family Systems; Intimacy; Prostate Cancer; Psychosexual Support; Relationships; Sex Therapy; Sexual Function; Treatment

Mesh:

Year:  2016        PMID: 27345218     DOI: 10.1016/j.jsxm.2016.05.013

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  11 in total

1.  Brief supportive-expressive group therapy for partners of men with early stage prostate cancer: lessons learned from a negative randomized controlled trial.

Authors:  Linda E Carlson; Codie R Rouleau; Michael Speca; John Robinson; Barry D Bultz
Journal:  Support Care Cancer       Date:  2017-01-07       Impact factor: 3.603

2.  A systematic review and meta-analysis of couple-based intervention on sexuality and the quality of life of cancer patients and their partners.

Authors:  Minjie Li; Carmen W H Chan; Ka Ming Chow; Jinnan Xiao; Kai Chow Choi
Journal:  Support Care Cancer       Date:  2019-12-24       Impact factor: 3.603

Review 3.  Current management strategy of treating patients with erectile dysfunction after radical prostatectomy: a systematic review and meta-analysis.

Authors:  Dechao Feng; Cai Tang; Shengzhuo Liu; Yubo Yang; Ping Han; Wuran Wei
Journal:  Int J Impot Res       Date:  2020-10-24       Impact factor: 2.896

4.  On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer.

Authors:  Lauren M Walker; Pablo Santos-Iglesias
Journal:  Arch Sex Behav       Date:  2020-02-18

Review 5.  Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem).

Authors:  Marigdalia K Ramirez-Fort; Paula Suarez; Margely Carrion; Daniel Weiner; Claire Postl; Ricardo Arribas; Mehdi Sayyah; Digna V Forta; M Junaid Niaz; Amir Feily; Christopher S Lange; Zhahedia Zhaythseff Fort; Migdalia Fort
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-30

6.  The effectiveness of psychological intervention for depression, anxiety, and distress in prostate cancer: a systematic review of literature.

Authors:  Rhea Mundle; Evans Afenya; Neeraj Agarwal
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-03-09       Impact factor: 5.554

7.  Psychosocial interventions for informal caregivers of people living with cancer.

Authors:  Charlene J Treanor; Olinda Santin; Gillian Prue; Helen Coleman; Chris R Cardwell; Peter O'Halloran; Michael Donnelly
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

8.  New Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications.

Authors:  Suzanne K Chambers; Melissa K Hyde; David P Smith; Suzanne Hughes; Susan Yuill; Sam Egger; Dianne L O'Connell; Kevin Stein; Mark Frydenberg; Gary Wittert; Jeff Dunn
Journal:  Psychooncology       Date:  2017-07       Impact factor: 3.894

9.  The Challenges of Enrollment and Retention: A Systematic Review of Psychosocial Behavioral Interventions for Patients With Cancer and Their Family Caregivers.

Authors:  Lixin Song; Yousef Qan'ir; Ting Guan; Peiran Guo; Shenmeng Xu; Ahrang Jung; Eno Idiagbonya; Fengyu Song; Erin Elizabeth Kent
Journal:  J Pain Symptom Manage       Date:  2021-04-30       Impact factor: 5.576

10.  Scandinavian Prostate Cancer Patients' Sexual Problems and Satisfaction With Their Sex Life Following Anti-Cancer Treatment.

Authors:  Gert Martin Hald; Mie Dahl Pind; Michael Borre; Theis Lange
Journal:  Sex Med       Date:  2018-07-13       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.